Latest News

Michael Lisanti, Interview with Frontiers on Covid-19

By Joanie in Lastest News on 23 May 2020

 SARS-CoV-2 may target senescent cells, which become more common with age –Michael Lisanti, Specialty Chief Editor of Frontiers in Oncology – Cancer Metabolism, on potential targets for the treatment of Covid-19.

Post CommentLeave a reply

Your email address will not be published. Required fields are marked *